Ursodiol
Product Images NDC 0591-3005

3 FDA label images from Actavis Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ursodiol (NDC 0591-3005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ursodiol Tablets 01

Ursodiol Tablets 01
Chemical structure of Ursodiol, showing its steroid backbone with hydroxyl groups and a carboxyl side chain.*
FDA Label Image

Ursodiol Tablets 02

Ursodiol Tablets 02
Label for Ursodiol Tablets, USP 250 mg by Actavis Pharma, Inc. Contains 100 tablets, prescription only. Label shows NDC 0591-2998-01 and includes manufacturer and distributor information with usage and storage instructions.*
FDA Label Image

Ursodiol Tablets 03

Ursodiol Tablets 03
Ursodiol 500 mg tablets label from Actavis Pharma, Inc. The label shows the proprietary name Ursodiol, strength 500 mg, and dosage form as tablets USP. It includes a quantity of 100 tablets, Rx only. Manufacturer details list Confab Laboratories in Quebec, Canada. The label also shows NDC 0591-3005-01 and includes warnings to keep out of the reach of children and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.